It’s always a good day when a new treatment, especially one for lung cancer, becomes available. It’s even better when the drug trial was stopped early because the results were so clear. Now, Tagrisso is the first adjuvant treatment approved for non-small cell lung cancer.Original Article
You may also like
Ninth Circuit Upholds FDA’s Authority to Regulate...
Skinny-Label Lives to See Another Day
Bring Out Your Meds! Bring Out Your Meds!
Homeopathic Industry Group Wants Court to Exclude It...
A Reversal on Sequencing? Proposed Legislation Would...
FDA Guidance Outlines a Framework for the Evaluation...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.